Histogram analysis of apparent diffusion coefficient within enhancing and nonenhancing tumor volumes in recurrent glioblastoma patients treated with bevacizumab (Q48787869)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Histogram analysis of apparent diffusion coefficient within enhancing and nonenhancing tumor volumes in recurrent glioblastoma patients treated with bevacizumab	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24805151

Histogram analysis of apparent diffusion coefficient within enhancing and nonenhancing tumor volumes in recurrent glioblastoma patients treated with bevacizumab (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24805151

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

David A Reardon

6

object named as

David A Reardon

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

8

object named as

Patrick Y Wen

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24805151

author name string

Rifaquat Rahman

1

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24805151

Alhafidz Hamdan

2

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24805151

Rebecca Zweifler

3

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24805151

Han Jiang

4

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24805151

Andrew D Norden

5

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24805151

Srinivasan Mukundan

7

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24805151

Raymond Y Huang

9

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24805151

publication date

8 May 2014

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24805151

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24805151

119

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24805151

1

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24805151

149-158

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24805151

An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant glioma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1464-8

21 January 2018

Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1464-8

21 January 2018

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1464-8

21 January 2018

Apparent diffusion coefficient of human brain tumors at MR imaging

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1464-8

21 January 2018

Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1464-8

21 January 2018

Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1464-8

21 January 2018

Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1464-8

21 January 2018

Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1464-8

21 January 2018

Volumetric analysis of functional diffusion maps is a predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in malignant gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1464-8

21 January 2018

Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1464-8

21 January 2018

Imaging response criteria for recurrent gliomas treated with bevacizumab: role of diffusion weighted imaging as an imaging biomarker

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1464-8

21 January 2018

Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1464-8

21 January 2018

Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1464-8

21 January 2018

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1464-8

21 January 2018

Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1464-8

21 January 2018

Diffusion tensor analysis of peritumoral edema using lambda chart analysis indicative of the heterogeneity of the microstructure within edema

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1464-8

21 January 2018

Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1464-8

21 January 2018

Diffusion magnetic resonance imaging detects pathologically confirmed, nonenhancing tumor progression in a patient with recurrent glioblastoma receiving bevacizumab

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1464-8

21 January 2018

Bevacizumab-induced diffusion-restricted lesions in malignant glioma patients

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1464-8

21 January 2018

Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging--correlation with tumor grade

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1464-8

21 January 2018

Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24805151

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrent glioblastoma: volumetric assessment and stratification of patient survival with early posttreatment magnetic resonance imaging in patients treated with bevacizumab

1 reference

https://pubmed.ncbi.nlm.nih.gov/24805151

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-014-1464-8

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24805151

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/24805151

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48787869&oldid=2210095408"